Research programme: SPL 029 series - Cybin
Alternative Names: Oral DMT series - Cybin; SPL-029 series; SPL029Latest Information Update: 12 Feb 2024
At a glance
- Originator Small Pharma
- Developer Cybin
- Class Dimethylamines; Neuropsychotherapeutics; Organic deuterium compounds; Small molecules; Tryptamines
- Mechanism of Action Serotonin 5-HT2A receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Mental disorders